results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
Published 5 months ago • 161 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:27
hyaluronidase for ha filler complications: dosage, timing & safety
-
2:41
israeli company on the edge of finding diabetes cure
-
3:23
final long-term follow-up results of the relaza2 study: mrd-guided treatment with aza in mds and aml
-
5:16
the evolution of al amyloidosis therapy
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
2:13
personalizing the timing of sct in patients with myelofibrosis
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
2:09
heart transplantation in attr amyloidosis
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv